Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Ontology highlight
ABSTRACT: Copper diethyldithiocarbamate (Cu(DDC)2) is the active anticancer agent generated when disulfiram (DSF) is provided in the presence of copper. To date, research directed toward repurposing DSF as an anticancer drug has focused on administration of DSF and copper in combination, efforts that have proven unsuccessful in clinical trials. This is likely due to the inability to form Cu(DDC)2 at relevant concentrations in regions of tumor growth. Little effort has been directed toward the development of Cu(DDC)2 because of the inherent aqueous insolubility of the complex. Here, we describe an injectable Cu(DDC)2 formulation prepared through a method that involves synthesis of Cu(DDC)2 inside the aqueous core of liposomes. Convection-enhanced
SUBMITTER: Wehbe M
PROVIDER: S-EPMC5459956 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA